Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) Cost of Revenue (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Cost of Revenue for 10 consecutive years, with $8.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cost of Revenue fell 75.86% year-over-year to $8.0 million, compared with a TTM value of -$20.3 million through Jun 2025, down 138.81%, and an annual FY2024 reading of $5.4 million, down 79.84% over the prior year.
  • Cost of Revenue was $8.0 million for Q2 2025 at SRx Health Solutions, up from $4.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $33.3 million in Q2 2024 and bottomed at -$40.0 million in Q4 2024.
  • Average Cost of Revenue over 5 years is $6.4 million, with a median of $7.3 million recorded in 2021.
  • Peak annual rise in Cost of Revenue hit 378.61% in 2024, while the deepest fall reached 873.58% in 2024.
  • Year by year, Cost of Revenue stood at $8.2 million in 2021, then decreased by 7.65% to $7.6 million in 2022, then plummeted by 32.01% to $5.2 million in 2023, then plummeted by 873.58% to -$40.0 million in 2024, then soared by 120.07% to $8.0 million in 2025.
  • Business Quant data shows Cost of Revenue for SRXH at $8.0 million in Q2 2025, $4.8 million in Q1 2025, and -$40.0 million in Q4 2024.